Research animal retirement and lifetime care, now available through Alpha Genesis. Professionally managed lifetime care for retired research primates, with expert social reintroduction into stable outdoor groups led by veterinary staff deeply experienced in laboratory-animal medicine.
Learn more
Rodent Studies
Pharmacology, PK/PD, toxicology, immunology, and surgical models in mice and rats, run by experienced technical teams under veterinary oversight.
Study capabilities
In vivo pharmacology, PK sampling, PK/PD modeling, and dose-response characterization.
Acute and repeat-dose toxicology, dose-ranging, tolerability, and biodistribution, GLP or non-GLP.
Immunogenicity, adjuvant evaluation, antibody and cellular immunity, and immune-challenge models.
Tumor-burden, autoimmune, inflammatory, and infectious-disease models.
Surgical model development, interventional procedures, and complex in-life work.
Sponsor-defined protocols, combination designs, and pilot and feasibility studies.
Mus musculus
Inbred, outbred, and transgenic models for pharmacology, immunology, oncology, and custom work.
Rattus norvegicus
Sprague-Dawley, Wistar, and other strains for toxicology, PK/PD, and surgical studies.
On request
Syrian hamsters, guinea pigs, gerbils, and cotton rats for infectious-disease and specialized models.

Welfare and data
Rigorous husbandry is what makes rodent data reproducible.
Controlled housing, daily clinical observations, defined humane endpoints, and experienced rodent technicians under veterinary oversight keep studies clean and consistent across cohorts.
Rigorous husbandry and veterinary oversight, backed by AAALAC accreditation, produce healthier rodents with consistent baselines and reproducible data.
Dosing, sampling, surgery, and in-life monitoring performed by a dedicated rodent team with deep hands-on experience.
When a program advances into nonhuman primates, the same organization carries it forward, so what you learn in rodents informs the work that follows.
A government and commercial study-execution history and audit-ready documentation support reliable timelines and consistent study quality.
Submit a protocol for review or contact our team to discuss feasibility, strain availability, timeline, and GLP or non-GLP options.
Yes. We support both GLP and non-GLP studies. For GLP work, documentation and study design are aligned to your IND-enabling and regulatory objectives. We recommend discussing your regulatory context during the initial protocol review so we can set up the design and documentation accordingly.